Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
View Older Stories
-
TD Cowen Reiterates Buy Rating on Amgen (AMGN)
-
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
-
TD Cowen Reiterates Buy Rating on Amgen (AMGN) as 'ROCA PH3 Horizon Shows Improved Safety'
-
AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
-
TD Cowen Reiterates Buy Rating on Amgen (AMGN)
-
TD Cowen Reiterates Buy Rating on Amgen (AMGN)
-
Amgen (AMGN) PT Raised to $383 at TD Cowen
-
TD Cowen Reiterates Buy Rating on Amgen (AMGN)
-
TD Cowen Reiterates Buy Rating on Amgen (AMGN)
-
TD Cowen Reiterates Buy Rating on Amgen (AMGN)
-
Amgen (AMGN) PT Raised to $381 at TD Cowen
-
AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
-
TD Cowen Starts Harpoon Therapeutics (HARP) at Outperform
-
AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT
-
AMGEN TO PRESENT AT THE 43RD ANNUAL TD COWEN HEALTHCARE CONFERENCE
-
Horizon Therapeutics seen worth up to $140/share in takeover
-
Pre-Open Movers: Bed Bath & Beyond Sinks on Update, PayPal Gains on Upgrade
-
AMGEN TO PRESENT AT THE 42ND ANNUAL COWEN HEALTHCARE CONFERENCE
-
Amgen To Present At The 2021 Annual Cowen IO Summit
-
Amgen To Present AT the Cowen 2nd Annual Virtual Oncology Innovation Summit
-
Amgen To Present At The Cowen 41st Annual Healthcare Conference
-
Amgen (AMGN) PT Lowered to $288 at Cowen
-
Amgen To Present At The Cowen 4th Annual IO Summit
-
Amgen (AMGN) PT Lowered to $294 at Cowen
-
Amgen (AMGN) Enbrel Decision Justifies 5-10% Stock Move - Cowen
-
Amgen (AMGN) PT Raised to $274 at Cowen
-
Amgen To Present At The Cowen 40th Annual Healthcare Conference
-
Amgen (AMGN) Otezla Deal 'Highly Accretive' - Cowen
-
Alexion Pharma (ALXN) Takeover By Amgen (AMGN) 'Highly Unlikely' - Cowen
-
German Court Ruling Positive for Amgen (AMGN), Negative for Regeneron (REGN) - Cowen
-
Amgen To Present At The Cowen and Company 39th Annual Healthcare Conference
-
Cowen Trasnfers Coverage on Amgen (AMGN) with an Outperform
-
Amgen (AMGN) PT Raised to $205 at Cowen Following 'Beat and Raise'
-
Amgen To Present At the Cowen and Company 38th Annual Health Care Conference
-
Drugmakers raise 2018 U.S. prices, stick to self-imposed limits
-
Amgen (AMGN) Raises Enbrel and Neulasta Prices - Cowen
-
Amgen quarterly profit tops expectations despite sales decline
-
Amgen (AMGN): LDL Guidelines Favorable For Amgen - Cowen
-
Cost controls help offset lower Amgen first-quarter drug sales
-
Cowen Reiterates Outperform Rating and $209 PT on Amgen (AMGN); 'Repatha's FOURIER Data Well Received By Specialists'
-
Amgen (AMGN) FOURIER Results 'Good Enough' - Cowen
-
Amgen To Present At The Cowen And Company 37th Annual Health Care Conference
-
Amgen fourth quarter profit tops Street view, cholesterol news lifts shares
-
Notable Analyst Rating Changes 11/8: (CTL) (ETE) (MRC) Upgraded; (CXRX) (HTZ) (IQNT) Downgraded
-
Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report
-
Streetinsider.com's Hot Lunchtime Reads 8/3: (XON) (WMT) (QRVO) (MRCY)
-
Trading Radar for 4/28: Ford (F), Amazon (AMZN), Viacom (VIAB), LinkedIn (LNKD), Pandora (P), Aetna (AET) Report
-
Amgen To Present At The Cowen And Company 36th Annual Health Care Conference
-
Notable Analyst Rating Changes 12/15: (V) (AMGN) (COH) Upgraded; (BTU) (GOGL) (WSTC) Downgraded
-
Pre-Open Stock Movers 09/08: (TE) (MDP) (FIT) Higher; (ACRX) (DNR) (INFN) Lower (more...)

